Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk

被引:34
|
作者
Park, SK
Yim, DS
Yoon, KS
Choi, IM
Choi, JY
Yoo, KY
Noh, DY
Choe, KJ
Ahn, SH
Hirvonen, A
Kang, D
机构
[1] Seoul Natl Univ, Coll Med, Canc Res Inst, Dept Prevent Med, Seoul 110799, South Korea
[2] Catholic Univ Korea, Seoul, South Korea
[3] Kyung Hee Univ, Seoul, South Korea
[4] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul 151, South Korea
[5] Seoul Natl Univ, Coll Med, Dept Surg, Seoul 151, South Korea
[6] Asan Med Ctr, Seoul, South Korea
[7] Inst Occupat Hlth, Dept Ind Hyg & Toxicol, Helsinki, Finland
[8] Konkuk Univ, Inst Med Sci, Chungju, South Korea
[9] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea
关键词
breast cancer; genetic polymorphism; GSTM1; GSTT1; COMT;
D O I
10.1007/s10549-004-0745-x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our previous studies suggested that both catechol O-methyl transferase ( COMT) and glutathione S-transferase ( GST) M1 and T1 genotypes are associated with breast cancer risk. Here we extended the studies to evaluate the potential combined effect of these genotypes in individual breast cancer risk. Incident breast cancer cases ( n = 202) and controls ( n = 299) with no previous cancer were recruited from three teaching hospitals in Seoul in 1996-1999. Information on putative risk factors was collected by interviewed questionnaire. PCR-based methods were used for the genotyping analyses. Odds ratios ( ORs) and 95% confidence ( CIs) intervals were estimated by unconditional logistic regression after adjustment for known or suspected risk factors of breast cancer. Among pre-menopausal women the low activity associated ( COMT*L) allele containing genotypes and the GSTM1 null genotype posed increased risks of breast cancer with ORs of 1.7 (95% CI = 1.0-2.8) and 1.7 (95% CI = 1.0-2.8), respectively. A marginally significant effect of GSTT1 null genotype was also observed when the total study population was considered (OR = 1.3, 95% CI = 1.0 - 2.1). When the combined genotype effects were examined, the concurrent lack of GSTM1 and GSTT1 genes posed a more than 2-fold risk of breast cancer (OR = 2.2, 95% CI = 1.2-3.9); this effect was mainly attributable in pre-menopausal women (OR = 3.2, 95% CI = 1.5-7.2). Moreover, the breast cancer risk increased in parallel with the number of COMT, GSTM1, and GSTT1 at-risk genotypes ( p for trend = 0.003). This association was particularly clear in pre-menopausal women among whom combination of all three high-risk genotypes posed a 4.1-fold breast cancer risk (95% CI = 1.4-12.7) compared with pre-menopausal women without at-risk genotypes ( p for trend = 0.001). The trend was more pronounced in women with BMI greater than 22 kg/m(2) ( p for trend < 0.001) and high-risk status of parity factor ( nulliparous or women with the first full term pregnancy at age of over 25-year-old) ( p for trend = 0.013). These results suggest the combined effect between reproductive factors and GSTM1, GSTT1 and COMT genotypes in human breast carcinogenesis.
引用
下载
收藏
页码:55 / 62
页数:8
相关论文
共 50 条
  • [1] Combined effect of GSTM1, GSTT1, and COMT genotypes in individual
    Sue Kyung Park
    Dong-seok Yim
    Kyung-sik Yoon
    In-mi Choi
    Ji-yeob Choi
    Keun-young Yoo
    Dong-young Noh
    Kuk-jin Choe
    Sei-hyun Ahn
    Ari Hirvonen
    Daehee Kang
    Breast Cancer Research and Treatment, 2004, 88 : 55 - 62
  • [2] GSTM1 and GSTT1 polymorphisms and postmenopausal breast cancer risk
    Zheng, W
    Wen, WQ
    Gustafson, DR
    Gross, M
    Cerhan, JR
    Folsom, AR
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 74 (01) : 9 - 16
  • [3] GSTM1 and GSTT1 polymorphisms and postmenopausal breast cancer risk
    Wei Zheng
    Wan-Qing Wen
    Deborah R. Gustafson
    Myron Gross
    James R. Cerhan
    Aaron R. Folsom
    Breast Cancer Research and Treatment, 2002, 74 : 9 - 16
  • [4] Cancer Risk and GSTM1 and GSTT1 Polymorphisms
    Cetta, Francesco
    Dhamo, Armand
    Moltoni, Laura
    Zangari, Rosalia
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2009, 117 (07) : A286 - A287
  • [5] Combined GSTM1 and GSTT1 null genotypes are associated with a lower risk of papillary thyroid cancer
    Lemos, M. C.
    Coutinho, E.
    Gomes, L.
    Carrilho, F.
    Rodrigues, F.
    Regateiro, F. J.
    Carvalheiro, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2008, 31 (06) : 542 - 545
  • [6] Combined GSTM1 and GSTT1 null genotypes are associated with a lower risk of papillary thyroid cancer
    M. C. Lemos
    E. Coutinho
    L. Gomes
    F. Carrilho
    F. Rodrigues
    F. J. Regateiro
    M. Carvalheiro
    Journal of Endocrinological Investigation, 2008, 31 : 542 - 545
  • [7] GSTM1 and GSTT1 genotypes in bladder and prostate cancer patients
    Lemos, M
    Silva, HA
    Furtado, AL
    Regateiro, FJ
    JOURNAL OF MEDICAL GENETICS, 1999, 36 : S46 - S46
  • [8] Combined GSTM1 and GSTT1 null genotypes are strong risk factors for atherogenesis in a Serbian population
    Grubisa, Ivana
    Otasevic, Petar
    Vucinic, Nada
    Milicic, Biljana
    Jozic, Tanja
    Krstic, Slobodan
    Milasin, Jelena
    GENETICS AND MOLECULAR BIOLOGY, 2018, 41 (01) : 35 - 40
  • [9] The impact of GSTM1/GSTT1 polymorphism for the risk of oral cancer
    Maximilian Krüger
    Andreas Max Pabst
    Benjamin Mahmoodi
    Burkhard Becker
    Peer Wolfgang Kämmerer
    Felix Peter Koch
    Clinical Oral Investigations, 2015, 19 : 1791 - 1797
  • [10] The impact of GSTM1/GSTT1 polymorphism for the risk of oral cancer
    Krueger, Maximilian
    Pabst, Andreas Max
    Mahmoodi, Benjamin
    Becker, Burkhard
    Kaemmerer, Peer Wolfgang
    Koch, Felix Peter
    CLINICAL ORAL INVESTIGATIONS, 2015, 19 (08) : 1791 - 1797